TMPRSS2 and cancer: The results obtained from the Oncomine database indicated that relative to normal tissues, the expression level of TMPRSS2 was reduced in many tumour tissues and cancers including breast, bladder, gastric, colorectal, lung, kidney, prostate, ovarian and sarcoma cancer.